IDE Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 118 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Small intestine
Negative control ⓘ Bone marrow
Important caveats
Reasons your observed band may differ from the expected size.
ⓘCalculated mass118 kDa
ⓘLocalizationCytoplasm, cytosol / Cell membrane
ⓘProcessing / PTMRecord-dependent
ⓘReactivityHuman / Mouse / Rat

Sample controls for IDE Western blot

🧪Use Small intestine as the first positive-control candidate and Bone marrow as the HPA Not detected negative candidate.
Positive control: Small intestine (High)
Negative control: Bone marrow (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for IDE

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source
Small intestine Reported tissue cells High Protein (HPA) HPA →
Stomach Reported tissue cells High Protein (HPA) HPA →
Heart muscle Reported tissue cells High Protein (HPA) HPA →
Skeletal muscle Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

Tissue Cell type Level Evidence Source
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Soft tissue Reported tissue cells Not detected Protein (HPA) HPA →
Section 1

What Is the Expected IDE Western Blot Band Size?

Use the product-observed 118 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
118 kDaMatches the authoritative product WB observation.
118 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected IDE appearancePlan around 118 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band118 kDa; use this as the primary experimental expectation.
Calculated mass118 kDa from UniProt P14735; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A01358-2.
Why is my band missing or off?
SituationLikely causeNext action
118 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.
Section 2

Real Curated IDE Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateHeart muscle
Gel %8-10%
Load20-30 µg total protein per lane
TransferWet/tank, extended transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA01358-2 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 4

Advanced IDE Western Blot Tips

Deeper troubleshooting and optimisation questions for IDE, answered from its protein features.

Which band should guide the blot?
Use 118 kDa, the observation attached to the authoritative A01358-2 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 118 kDa expectation.
Which positive control should I start with?
Start with Small intestine, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bone marrow as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for IDE Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A01358-2 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC6675974, PMC4761760.
Boster reagents

IDE Western Blot Reagents

Human/Mouse/Rat-reactive IDE Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for IDE using A01358-2; observed band 118 kDa
Anti-Insulin degrading enzyme/IDE Antibody Picoband®
Cat # A01358-2
Reactivity: Human, Mouse, Rat

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.